Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/20/24 18:34 | 9/18/24 | ZBIO | Health | Drug | Pharmaceutical Preparations | Moulder Leon O Jr | MA | DO | CEO | 1 | P.m | 361 | 18.04 | 0 | 20 | 1 | 1,833 | I | ||||||||||||||
9/18/24 16:15 | 9/16/24 | ZBIO | Health | Drug | Pharmaceutical Preparations | Enavate Sciences Gp, LLC | CA | T | 1 | P.d | 15,000 | 17.00 | 0 | 882 | 31 | 3,761 | I | |||||||||||||||
9/17/24 20:56 | 9/16/24 | ZBIO | Health | Drug | Pharmaceutical Preparations | Fairmount Funds Management LLC | PA | D | 2 | P.d | 10,200 | 17.00 | 0 | 600 | 46 | 1,893 | I | |||||||||||||||
9/17/24 19:52 | 9/13/24 | ZBIO | Health | Drug | Pharmaceutical Preparations | Lu Hongbo | MA | D | 1 | P | 1,000 | 17.00 | 0 | 59 | 59 | I | ||||||||||||||||
9/16/24 20:57 | 9/16/24 | ZBIO | Health | Drug | Pharmaceutical Preparations | Enright Patrick G | MA | D | 1 | P.d | 7,480 | 17.00 | 0 | 440 | 132 | 775 | I | |||||||||||||||
9/16/24 20:54 | 9/16/24 | ZBIO | Health | Drug | Pharmaceutical Preparations | Nunn Jason Raleigh | PA | D | 1 | P.d | 15,000 | 17.00 | 0 | 882 | 41 | 3,057 | I | |||||||||||||||
9/16/24 20:51 | 9/16/24 | ZBIO | Health | Drug | Pharmaceutical Preparations | Sr One Capital Management, LLC | PA | T | 1 | P.d | 38,000 | 17.00 | 0 | 2,235 | 84 | 4,912 | I |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |